I guess the highlights are:
- discussions with potential partners for trof ex-NA progressing, with strong interest received from multiple parties
- Revised Angelman syndrome protocol has been submitted to FDA, Phelan-McDermid and Pitt Hopkins protocols to be submitted shortly
Ann: Q4 2021 quarterly activity and cash flow report, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
0.000(0.00%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $1.787M | 138.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 222 | $12.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.97 | 610 | 11 |
View Market Depth
| Last trade - 12.27pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |